Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068600 · ClinicalTrials.gov registry record · Phase 3
Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 318
- Enrollment target
NCT01068600 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 318 participants.
The verdict
NCT01068600, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 318 participants
- Enrollment target
Study Summary
This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
Interventions
- DRUG Placebo to indacaterol
- DRUG Indacaterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068600
The ClinicalTrials.gov registry entry for NCT01068600 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo to indacaterol is the first listed.
NCT01068600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068600 about?
NCT01068600 is a clinical study titled "Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks". This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
What is the current status of trial NCT01068600?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 318 participants. The study started on 2010-01.
What interventions are being tested in trial NCT01068600?
The interventions under investigation include: Placebo to indacaterol (DRUG), Indacaterol (DRUG).
Who is sponsoring clinical trial NCT01068600?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.